Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Left Ventricular Function in Patients with Chronic Obstructive Pulmonary Disease

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We assessed the left ventricular function in 24 patients with severe (forced expiratory volume in 1 sec < 50% of predicted) chronic obstructive pulmonary disease (COPD) and in 21 normal people. We measured the left ventricular systolic time intervals (STI) and echocardiographic left ventricular diameters, volumes, cardiac index, stroke volume index, echo ejection fraction and functional mean rate of circumferential fiber shortening (Vcf). In 13 of the 24 patients with COPD the mean pulmonary artery pressure and pulmonary artery wedge pressure were recorded. The STI in the patients with COPD were found abnormal while the echocardiographic parameters and pulmonary wedge pressure were normal. 1 patient had a high pulmonary arterial wedge pressure and a low Vcf. 2 patients had an ejection fraction < 60%, but in only 1 of these the Vcf was low. No patient had all three parameters abnormal. We conclude that in patients with COPD the increased right ventricular afterload and the interaction between left and right ventricles are responsible for the abnormal left ventricular STI, while the left ventricular function is normal.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          1981
          1981
          07 November 2008
          : 67
          : 2
          : 73-80
          Affiliations
          Pulmonary Section, Department of Medicine, University of Thessaloniki
          Article
          173231 Cardiology 1981;67:73–80
          10.1159/000173231
          7273040
          © 1981 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 8
          Categories
          Original Paper

          Comments

          Comment on this article